Molecular Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 29, 2025
Abstract
Alzheimer’s
disease
(AD)
is
a
debilitating
neurodegenerative
that
marked
by
profound
neurovascular
dysfunction
and
significant
cell-specific
alterations
in
the
brain
vasculature.
Recent
advances
high
throughput
single-cell
transcriptomics
technology
have
enabled
study
of
human
vasculature
at
an
unprecedented
depth.
Additionally,
understudied
niche
cerebrovascular
cells,
such
as
endothelial
mural
their
subtypes
been
scrutinized
for
understanding
cellular
transcriptional
heterogeneity
AD.
Here,
we
provide
overview
rich
signatures
derived
from
recent
single-nucleus
transcriptomic
studies
vascular
cells
implications
targeted
therapy
We
conducted
in-depth
literature
search
using
Medline
Covidence
to
identify
pertinent
AD
utilized
technologies
post-mortem
tissue
focusing
on
differences
cell
types
cognitively
normal
older
adults.
also
discuss
impaired
crosstalk
between
neuroglial
units,
well
astrocytes
contextualize
findings
distinct
smooth
muscle
fibroblasts,
pericytes
highlight
pathways
potential
therapeutic
interventions
concerted
multi-omic
effort
with
spatial
technology,
neuroimaging,
neuropathology.
Overall,
detailed
account
crucial
unit.
Graphical
Endothelial
mediate
dysregulated
cell-cell
interactions
The
unit
(NVU)
composed
various
types,
including
(pericytes,
cells),
fibroblast
neurons,
microglia,
astrocytes.
Dysregulated
involve
multiple
pathways,
notably
immune
responses,
angiogenesis
common
both
cells.
involving
neuroinflammation
amyloid
clearance
are
prominent
while
exhibit
related
growth
factors,
cytoskeletal
remodeling
synaptic
function.
In
addition,
within
NVU
gliovascular
(GVU)
altered
AD,
communication
evident,
increased
pericytes,
decreased
astrocytes,
neurons.
Figure
created
BioRender.com.
Abbreviations:
Alzheimer's
disease;
NVU,
Neurovascular
unit;
CNS,
Central
Nervous
System.
Cells,
Journal Year:
2024,
Volume and Issue:
13(3), P. 286 - 286
Published: Feb. 5, 2024
The
key
to
the
effective
treatment
of
neurodegenerative
disorders
is
a
thorough
understanding
their
pathomechanism.
Neurodegeneration
and
neuroinflammation
are
mutually
propelling
brain
processes.
An
impairment
glymphatic
system
function
in
neurodegeneration
contributes
progression
pathological
question
arises
as
how
related.
This
review
highlights
direct
indirect
influence
these
two
seemingly
independent
Protein
aggregates,
characteristic
feature
neurodegeneration,
correlated
with
clearance
neuroinflammation.
Glial
cells
cannot
be
overlooked
when
considering
neuroinflammatory
Astrocytes
essential
for
functioning
play
crucial
role
inflammatory
responses
central
nervous
system.
It
imperative
acknowledge
significance
AQP4,
protein
that
exhibits
high
degree
polarization
astrocytes
AQP4
influences
processes
have
not
yet
been
clearly
delineated.
Another
interesting
issue
gut–brain
axis
microbiome,
which
potentially
impact
discussed
A
discussion
correlation
between
may
contribute
exploring
pathomechanism
neurodegeneration.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 2, 2025
Alzheimer's
disease
is
characterized
by
progressive
amyloid
deposition
and
cognitive
decline,
yet
the
pathological
mechanisms
treatments
remain
elusive.
Here
we
report
therapeutic
potential
of
low-intensity
40
hertz
blue
light
exposure
in
a
5xFAD
mouse
model
disease.
Our
findings
reveal
that
treatment
prevents
memory
decline
4-month-old
mice
motivation
loss
14-month-old
mice,
accompanied
restoration
glial
water
channel
aquaporin-4
polarity,
improved
brain
drainage
efficiency,
reduction
hippocampal
lipid
accumulation.
We
further
demonstrate
beneficial
effects
are
mediated
through
activation
vLGN/IGL-Re
visual
circuit.
Notably,
concomitant
use
anti-Aβ
antibody
with
demonstrates
soluble
Aβ
clearance
performance
mice.
These
offer
functional
evidence
on
Aβ-related
pathologies
suggest
its
as
supplementary
strategy
to
augment
efficacy
antibody-based
therapy.
Treatments
for
(AD)
limited.
Here,
authors
show
activates
circuit
boost
glymphatic
drainage,
enhances
memory,
motivation,
therapy
AD.
Trends in Neurosciences,
Journal Year:
2024,
Volume and Issue:
47(4), P. 289 - 302
Published: March 22, 2024
Selective
vulnerability
of
specific
brain
regions
and
cell
populations
is
a
hallmark
neurodegenerative
disorders.
Mechanisms
selective
involve
neuronal
heterogeneity,
functional
specializations,
differential
sensitivities
to
stressors
pathogenic
factors.
In
this
review
we
discuss
the
growing
body
literature
suggesting
that,
like
neurons,
astrocytes
are
heterogeneous
specialized,
respond
integrate
diverse
inputs,
induce
effects
on
function.
disease,
undergo
specific,
context-dependent
changes
that
promote
different
trajectories
outcomes.
We
propose
contribute
through
maladaptive
transitions
context-divergent
phenotypes
impair
functions.
Further
studies
multifaceted
roles
in
disease
may
provide
new
therapeutic
approaches
enhance
resilience
against
Cell Discovery,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Aug. 6, 2024
Abstract
The
glymphatic-lymphatic
system
is
increasingly
recognized
as
fundamental
for
the
homeostasis
of
brain
milieu
since
it
defines
cerebral
spinal
fluid
flow
in
parenchyma
and
eliminates
metabolic
waste.
Animal
human
studies
have
uncovered
several
important
physiological
factors
regulating
glymphatic
including
sleep,
aquaporin-4,
hemodynamic
factors.
Yet,
our
understanding
modulation
limited,
which
has
hindered
development
glymphatic-based
treatment
aging
neurodegenerative
disorders.
Here,
we
present
evidence
from
fluorescence
tracing,
two-photon
recording,
dynamic
contrast-enhanced
magnetic
resonance
imaging
analyses
that
40
Hz
light
flickering
enhanced
influx
efflux
independently
anesthesia
an
effect
attributed
to
increased
astrocytic
aquaporin-4
polarization
vasomotion.
Adenosine-A
2A
receptor
(A
R)
signaling
emerged
neurochemical
underpinning
flickering-induced
enhancement
flow,
based
on
cerebrofluid
adenosine
levels,
abolishment
by
pharmacological
or
genetic
inactivation
equilibrative
nucleotide
transporters-2
A
R,
physical
functional
R–aquaporin-4
interaction
astrocytes.
These
findings
establish
a
novel
non-invasive
strategy
with
translational
potential
relieve
Journal of Alzheimer s Disease,
Journal Year:
2024,
Volume and Issue:
99(2), P. 447 - 470
Published: April 23, 2024
Mounting
evidence
indicates
that
a
physiological
function
of
amyloid-β
(Aβ)
is
to
mediate
neural
activity-dependent
homeostatic
and
competitive
synaptic
plasticity
in
the
brain.
I
have
previously
summarized
lines
supporting
this
hypothesis
highlighted
similarities
between
Aβ
anti-microbial
peptides
mediating
cell/synapse
competition.
In
cell
competition,
deploy
multitude
mechanisms
ensure
both
self-protection
competitor
elimination.
Here
review
recent
studies
showing
similar
are
at
play
Aβ-mediated
synapse
competition
perturbations
these
underpin
Alzheimer’s
disease
(AD).
Specifically,
discuss
ApoE,
two
crucial
players
AD,
co-operate
regulation
Glial
ApoE
promotes
by
increasing
production
trophic
monomeric
inhibiting
its
assembly
into
toxic
oligomers.
Conversely,
oligomers,
once
assembled,
promote
elimination
synapses
via
direct
activity
amplification
“eat-me”
signals
promoting
weak
synapses.
further
summarize
neuronal
may
be
part
gene
regulatory
network
normally
plasticity,
explaining
selective
vulnerability
expressing
neurons
AD
brains.
Lastly,
sleep
key
Aβ-orchestrated
which
not
only
induced
but
also
required
for
underlining
link
AD.
Together,
results
strongly
argue
gone
awry,
novel
perspective
research.
NeuroImage,
Journal Year:
2024,
Volume and Issue:
288, P. 120524 - 120524
Published: Jan. 24, 2024
Arterial
pulsation
has
been
suggested
as
a
key
driver
of
paravascular
cerebrospinal
fluid
flow,
which
is
the
foundation
glymphatic
clearance.
However,
whether
intracranial
arterial
pulsatility
associated
with
markers
in
humans
not
yet
studied.
Seventy-three
community
participants
were
enrolled
study.
4D
phase-contrast
magnetic
resonance
imaging
(MRI)
was
used
to
quantify
hemodynamic
parameters
including
flow
index
(PIflow)
and
area
(PIarea)
from
13
major
intracerebral
segments.
Three
presumed
neuroimaging
system
measured:
dilation
perivascular
space
(PVS),
diffusivity
along
(ALPS),
volume
fraction
free
water
(FW)
white
matter.
We
explored
relationships
between
PIarea,
PIflow,
markers,
controlling
for
related
covariates.
PIflow
internal
carotid
artery
(ICA)
C2
segment
(OR,
1.05;
95%
CI,
1.01-1.10,
per
0.01
increase
PI)
C4
1.01-1.09)
positively
basal
ganglia
PVS,
ICA
1.06,
1.02-1.10)
correlated
PVS
ALPS
basilar
(β,
-0.273,
p,
0.046)
PIarea
-0.239,
0.041)
C7
segments
-0.238,
0.037).
Intracranial
system,
but
results
consistent
across
different
markers.
Further
studies
are
warranted
confirm
these
findings.
Alzheimer s Research & Therapy,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: April 5, 2024
Abstract
Background
The
aggregation
and
spread
of
misfolded
amyloid
structured
proteins,
such
as
tau
α-synuclein,
are
key
pathological
features
associated
with
neurodegenerative
disorders,
including
Alzheimer’s
Parkinson’s
disease.
These
proteins
possess
a
prion-like
property,
enabling
their
transmission
from
cell
to
leading
propagation
throughout
the
central
peripheral
nervous
systems.
While
mechanisms
underlying
intracellular
still
being
elucidated,
targeting
extracellular
space
has
emerged
potential
therapeutic
approach.
glymphatic
system,
brain-wide
pathway
responsible
for
clearing
metabolic
waste
gained
attention
promising
target
removing
these
toxic
proteins.
Methods
In
this
study,
we
investigated
impact
long-term
modulation
function
on
by
chronically
treating
mouse
model
pharmacological
inhibitor
AQP4,
TGN-020.
Thy1-hTau.P301S
mice
were
intracerebrally
inoculated
into
hippocampus
overlying
cortex,
subsequently
treated
TGN-020
(3
doses/week,
50
mg/kg
TGN-020,
i.p.)
10-weeks.
During
time,
animal
memory
was
studied
using
cognitive
behavioural
tasks,
structural
MR
images
acquired
brain
in
vivo
prior
extraction
immunohistochemical
characterisation.
Results
Our
findings
demonstrate
increased
transhemispheric
following
inhibition
clearance.
Moreover,
disruption
system
aggravated
recognition
exacerbated
regional
changes
volume
detected
model.
When
initiation
drug
treatment
delayed
several
weeks
post-inoculation,
alterations
attenuated.
Conclusions
results
indicate
that
modulating
AQP4
and,
consequently,
clearance,
it
is
possible
modify
brain,
particularly
during
initial
stages
highlight
critical
role
preserving
healthy
homeostasis
offer
valuable
insights
implications
managing
diseases
characterized
protein
spread.
Glia,
Journal Year:
2024,
Volume and Issue:
72(5), P. 982 - 998
Published: Feb. 16, 2024
Abstract
The
glymphatic
system
transports
cerebrospinal
fluid
(CSF)
into
the
brain
via
arterial
perivascular
spaces
and
removes
interstitial
from
along
perivenous
white
matter
tracts.
This
directional
flow
supports
clearance
of
metabolic
wastes
produced
by
brain.
Glymphatic
transport
is
facilitated
aquaporin‐4
(AQP4)
water
channels,
which
are
enriched
in
astrocytic
vascular
endfeet
comprising
outer
boundary
space.
Yet,
prior
studies
AQP4
function
have
relied
on
genetic
models,
or
correlated
altered
expression
with
disease
states.
Herein,
we
sought
to
pharmacologically
manipulate
inhibitor
AER‐271
assess
contribution
mouse
Administration
inhibited
influx
as
measured
CSF
tracer
infused
cisterna
magna
increases
volume
diffusion‐weighted
MRI.
Furthermore,
efflux
assessed
an
vivo
assay.
Importantly,
did
not
affect
localization
endfeet,
nor
any
effect
deficient
mice.
Since
acute
pharmacological
inhibition
directly
decreased
wild‐type
but
mice,
foresee
a
new
tool
for
manipulation
rodent
Alzheimer s Research & Therapy,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: May 21, 2024
Abstract
Alzheimer’s
disease
(AD)
poses
a
significant
public
health
problem,
affecting
millions
of
people
across
the
world.
Despite
decades
research
into
therapeutic
strategies
for
AD,
effective
prevention
or
treatment
this
devastating
disorder
remains
elusive.
In
review,
we
discuss
potential
photobiomodulation
(PBM)
preventing
and
alleviating
AD-associated
pathologies,
with
focus
on
biological
mechanisms
underlying
therapy.
Future
directions
guidance
clinical
practice
non-invasive
non-pharmacological
therapy
are
also
highlighted.
The
available
evidence
indicates
that
different
paradigms,
including
transcranial
systemic
PBM,
along
recently
proposed
remote
all
could
be
promising
AD.
PBM
exerts
diverse
effects,
such
as
enhancing
mitochondrial
function,
mitigating
neuroinflammation
caused
by
activated
glial
cells,
increasing
cerebral
perfusion,
improving
glymphatic
drainage,
regulating
gut
microbiome,
boosting
myokine
production,
modulating
immune
system.
We
suggest
may
serve
powerful
intervention